View Item 

Show simple item record

White paper: Oncofertility in pediatric patients with Wilms tumor
dc.contributor.authorPerk, M. E. Madeleine
dc.contributor.authorCost, Nicholas G.
dc.contributor.authorBos, Annelies M. E.
dc.contributor.authorBrannigan, Robert
dc.contributor.authorChowdhury, Tanzina
dc.contributor.authorDavidoff, Andrew M.
dc.contributor.authorDaw, Najat C.
dc.contributor.authorDome, Jeffrey S.
dc.contributor.authorEhrlich, Peter
dc.contributor.authorGraf, Norbert
dc.contributor.authorGeller, James
dc.contributor.authorKalapurakal, John
dc.contributor.authorKieran, Kathleen
dc.contributor.authorMalek, Marcus
dc.contributor.authorMcAleer, Mary F.
dc.contributor.authorMullen, Elizabeth
dc.contributor.authorPater, Luke
dc.contributor.authorPolanco, Angela
dc.contributor.authorRomao, Rodrigo
dc.contributor.authorSaltzman, Amanda F.
dc.contributor.authorWalz, Amy L.
dc.contributor.authorWoods, Andrew D.
dc.contributor.authorHeuvel-Eibrink, Marry M.
dc.contributor.authorFernandez, Conrad V.
dc.date.accessioned2022-08-02T18:56:19Z
dc.date.available2023-10-02 14:56:17en
dc.date.available2022-08-02T18:56:19Z
dc.date.issued2022-09-15
dc.identifier.citationPerk, M. E. Madeleine; Cost, Nicholas G.; Bos, Annelies M. E.; Brannigan, Robert; Chowdhury, Tanzina; Davidoff, Andrew M.; Daw, Najat C.; Dome, Jeffrey S.; Ehrlich, Peter; Graf, Norbert; Geller, James; Kalapurakal, John; Kieran, Kathleen; Malek, Marcus; McAleer, Mary F.; Mullen, Elizabeth; Pater, Luke; Polanco, Angela; Romao, Rodrigo; Saltzman, Amanda F.; Walz, Amy L.; Woods, Andrew D.; Heuvel-Eibrink, Marry M. ; Fernandez, Conrad V. (2022). "White paper: Oncofertility in pediatric patients with Wilms tumor." International Journal of Cancer 151(6): 843-858.
dc.identifier.issn0020-7136
dc.identifier.issn1097-0215
dc.identifier.urihttps://hdl.handle.net/2027.42/173084
dc.description.abstractThe survival of childhood Wilms tumor is currently around 90%, with many survivors reaching reproductive age. Chemotherapy and radiotherapy are established risk factors for gonadal damage and are used in both COG and SIOP Wilms tumor treatment protocols. The risk of infertility in Wilms tumor patients is low but increases with intensification of treatment including the use of alkylating agents, whole abdominal radiation or radiotherapy to the pelvis. Both COG and SIOP protocols aim to limit the use of gonadotoxic treatment, but unfortunately this cannot be avoided in all patients. Infertility is considered one of the most important late effects of childhood cancer treatment by patients and their families. Thus, timely discussion of gonadal damage risk and fertility preservation options is important. Additionally, irrespective of the choice for preservation, consultation with a fertility preservation (FP) team is associated with decreased patient and family regret and better quality of life. Current guidelines recommend early discussion of the impact of therapy on potential fertility. Since most patients with Wilms tumors are prepubertal, potential FP methods for this group are still considered experimental. There are no proven methods for FP for prepubertal males (testicular biopsy for cryopreservation is experimental), and there is just a single option for prepubertal females (ovarian tissue cryopreservation), posing both technical and ethical challenges. Identification of genetic markers of susceptibility to gonadotoxic therapy may help to stratify patient risk of gonadal damage and identify patients most likely to benefit from FP methods.What’s new?Wilms tumor (WT), a childhood kidney cancer, has a survival rate of around 90%. Because most patients survive to reproductive age, treatment decisions must take into account the risk of gonadal damage. Discussing infertility risk and fertility preservation (FP) is associated with decreased patient and family regret and better quality of life. Here, the authors present an overview of the evidence regarding the future fertility after WT treatment, collected through a unique global collaboration between Children’s Oncology Group (COG) and Societe Internationale D’oncologie Pediatrique (SIOP). They describe options for FP as well as ethical and genetic considerations, which may guide personalized risk prediction and selection of patients at risk of chemotherapy or radiotherapy induced gonadal impairment.
dc.publisherJohn Wiley & Sons, Inc.
dc.subject.otherfertility preservation
dc.subject.othergonadal damage
dc.subject.otherpediatric cancer
dc.subject.otherWilms tumor
dc.titleWhite paper: Oncofertility in pediatric patients with Wilms tumor
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelOncology and Hematology
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/173084/1/ijc34006_am.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/173084/2/ijc34006.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/173084/3/ijc34006-sup-0001-Supinfo.pdf
dc.identifier.doi10.1002/ijc.34006
dc.identifier.sourceInternational Journal of Cancer
dc.identifier.citedreferenceFranik S, Hoeijmakers Y, D’Hauwers K, et al. Klinefelter syndrome and fertility: sperm preservation should not be offered to children with Klinefelter syndrome. Hum Reprod. 2016; 31 ( 9 ): 1952 - 1959.
dc.identifier.citedreferenceShah R. Surgical sperm retrieval: techniques and their indications. Indian J Urol. 2011; 27 ( 1 ): 102 - 109.
dc.identifier.citedreferenceLopategui DM, Yechieli R, Ramasamy R. Oncofertility in sarcoma patients. Transl Androl Urol. 2017; 6 ( 5 ): 951 - 958.
dc.identifier.citedreferenceAdank MC, van Dorp W, Smit M, et al. Electroejaculation as a method of fertility preservation in boys diagnosed with cancer: a single-center experience and review of the literature. Fertil Steril. 2014; 102 ( 1 ): 199 - 205 e1.
dc.identifier.citedreferenceSegers H, van den Heuvel-Eibrink MM, Pritchard-Jones K, et al. Management of adults with Wilms’ tumor: recommendations based on international consensus. Expert Rev Anticancer Ther. 2011; 11 ( 7 ): 1105 - 1113.
dc.identifier.citedreferenceBisharah M, Tulandi T. Laparoscopic preservation of ovarian function: an underused procedure. Am J Obstet Gynecol. 2003; 188 ( 2 ): 367 - 370.
dc.identifier.citedreferenceAnderson RA, Baird DT. The development of ovarian tissue cryopreservation in Edinburgh: translation from a rodent model through validation in a large mammal and then into clinical practice. Acta Obstet Gynecol Scand. 2019; 98 ( 5 ): 545 - 549.
dc.identifier.citedreferenceDolmans MM, Donnez J. Fertility preservation in women for medical and social reasons: oocytes vs ovarian tissue. Best Pract Res Clin Obstet Gynaecol. 2021; 70: 63 - 80.
dc.identifier.citedreferenceBertoldo MJ, Smitz J, Wu LE, Lee HC, Woodruff TK, Gilchrist RB. Prospects of rescuing young eggs for oncofertility. Trends Endocrinol Metab. 2020; 31 ( 10 ): 708 - 711.
dc.identifier.citedreferenceDonnez J, Dolmans MM. Fertility preservation in women. N Engl J Med. 2017; 377 ( 17 ): 1657 - 1665.
dc.identifier.citedreferenceTelfer EE. Future developments: in vitro growth (IVG) of human ovarian follicles. Acta Obstet Gynecol Scand. 2019; 98 ( 5 ): 653 - 658.
dc.identifier.citedreferenceTelfer EE, Andersen CY. In vitro growth and maturation of primordial follicles and immature oocytes. Fertil Steril. 2021; 115 ( 5 ): 1116 - 1125.
dc.identifier.citedreferenceBenoit M, Chiles K, Hsieh M. The landscape of coverage for fertility preservation in male pediatric patients. Urol Pract. 2018; 5 ( 3 ): 198 - 204.
dc.identifier.citedreferenceDupree JM, Dickey RM, Lipshultz LI. Inequity between male and female coverage in state infertility laws. Fertil Steril. 2016; 105 ( 6 ): 1519 - 1522.
dc.identifier.citedreferenceSalama M, Ataman-Millhouse L, Sobral F, et al. Barriers and opportunities of oncofertility practice in nine developing countries and the emerging oncofertility professional engagement network. JCO Glob Oncol. 2020; 6: 369 - 374.
dc.identifier.citedreferenceGrootens-Wiegers P, Hein IM, van den Broek JM, de Vries MC. Medical decision-making in children and adolescents: developmental and neuroscientific aspects. BMC Pediatr. 2017; 17 ( 1 ): 120.
dc.identifier.citedreferenceVan Den Broecke R, Pennings G, Van Der Elst J, Liu J, Dhont M. Ovarian tissue cryopreservation: therapeutic prospects and ethical reflections. Reprod Biomed Online. 2001; 3 ( 3 ): 179 - 184.
dc.identifier.citedreferenceDeepinder F, Agarwal A. Approach to fertility preservation in adult and pre-pubertal males (chapter 27). In: Seli E, Agarwal A, eds. Fertility Preservation Emerging Technologies an Clinical Applications. New York: Springer; 2012.
dc.identifier.citedreferencePatrizio P. Ethical discussions in approaching fertility preservation (chapter 2). In: Seli E, Agarwal A, eds. Fertility Preservation Emerging Technologies an Clinical Applications. New York: Springer; 2012.
dc.identifier.citedreferenceMultidisciplinary Working Group convened by the British Fertility S. A strategy for fertility services for survivors of childhood cancer. Hum Fertil (Camb). 2003; 6 ( 2 ): A1 - A39.
dc.identifier.citedreferenceWallace WH, Anderson RA, Irvine DS. Fertility preservation for young patients with cancer: who is at risk and what can be offered? Lancet Oncol. 2005; 6 ( 4 ): 209 - 218.
dc.identifier.citedreferencePastore G, Znaor A, Spreafico F, Graf N, Pritchard-Jones K, Steliarova-Foucher E. Malignant renal tumours incidence and survival in European children (1978-1997): report from the Automated Childhood Cancer Information System project. Eur J Cancer. 2006; 42 ( 13 ): 2103 - 2114.
dc.identifier.citedreferenceHol JA, Lopez-Yurda MI, Van Tinteren H, et al. Prognostic significance of age in 5631 patients with Wilms tumour prospectively registered in International Society of Paediatric Oncology (SIOP) 93-01 and 2001. PLoS One. 2019; 14 ( 8 ): e0221373.
dc.identifier.citedreferenceHealth NIo. Children’s Assent to Clinical Trial Participation; 2005. https://www.cancer.gov/about-cancer/treatment/clinical-trials/patient-safety/childrens-assent. Accessed November 18, 2021.
dc.identifier.citedreferenceMayer R, Moreno R. Nine ways to reduce cognitive load in multimedia learning. Educ Psychol. 2003; 38: 43 - 52.
dc.identifier.citedreferenceElster N. Legal aspects of fertility preservation (chapter 42). In: Donnez J, Kim S, eds. Principles and Practice of Fertility Preservation. Cambridge: Cambridge University Press; 2011.
dc.identifier.citedreferenceCorkum KS, Rhee DS, Wafford QE, et al. Fertility and hormone preservation and restoration for female children and adolescents receiving gonadotoxic cancer treatments: a systematic review. J Pediatr Surg. 2019; 54 ( 11 ): 2200 - 2209.
dc.identifier.citedreferencevan Dorp W, van den Heuvel-Eibrink MM, Stolk L, et al. Genetic variation may modify ovarian reserve in female childhood cancer survivors. Hum Reprod. 2013; 28 ( 4 ): 1069 - 1076.
dc.identifier.citedreferencevan der Kooi ALF, van Dijk M, Broer L, et al. Possible modification of BRSK1 on the risk of alkylating chemotherapy-related reduced ovarian function. Hum Reprod. 2021; 36 ( 4 ): 1120 - 1133.
dc.identifier.citedreferenceDay FR, Ruth KS, Thompson DJ, et al. Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair. Nat Genet. 2015; 47 ( 11 ): 1294 - 1303.
dc.identifier.citedreferenceDay FR, Thompson DJ, Helgason H, et al. Genomic analyses identify hundreds of variants associated with age at menarche and support a role for puberty timing in cancer risk. Nat Genet. 2017; 49 ( 6 ): 834 - 841.
dc.identifier.citedreferenceHe C, Kraft P, Chasman DI, et al. A large-scale candidate gene association study of age at menarche and age at natural menopause. Hum Genet. 2010; 128 ( 5 ): 515 - 527.
dc.identifier.citedreferencePerry JR, Corre T, Esko T, et al. A genome-wide association study of early menopause and the combined impact of identified variants. Hum Mol Genet. 2013; 22 ( 7 ): 1465 - 1472.
dc.identifier.citedreferencePerry JR, Stolk L, Franceschini N, et al. Meta-analysis of genome-wide association data identifies two loci influencing age at menarche. Nat Genet. 2009; 41 ( 6 ): 648 - 650.
dc.identifier.citedreferenceStolk L, Zhai G, van Meurs JB, et al. Loci at chromosomes 13, 19 and 20 influence age at natural menopause. Nat Genet. 2009; 41 ( 6 ): 645 - 647.
dc.identifier.citedreferenceBrooke RJ, Im C, Wilson CL, et al. A high-risk haplotype for premature menopause in childhood cancer survivors exposed to gonadotoxic therapy. J Natl Cancer Inst. 2018; 110 ( 8 ): 895 - 904.
dc.identifier.citedreferenceByrne J, Grabow D, Campbell H, et al. PanCareLIFE: the scientific basis for a European project to improve long-term care regarding fertility, ototoxicity and health-related quality of life after cancer occurring among children and adolescents. Eur J Cancer. 2018; 103: 227 - 237.
dc.identifier.citedreferencevan der Kooi ALF, Clemens E, Broer L, et al. Genetic variation in gonadal impairment in female survivors of childhood cancer: a PanCareLIFE study protocol. BMC Cancer. 2018; 18 ( 1 ): 930.
dc.identifier.citedreferenceShu W, Guan S, Yang X, et al. Genetic markers in CYP2C19 and CYP2B6 for prediction of cyclophosphamide’s 4-hydroxylation, efficacy and side effects in Chinese patients with systemic lupus erythematosus. Br J Clin Pharmacol. 2016; 81 ( 2 ): 327 - 340.
dc.identifier.citedreferenceSu HI, Sammel MD, Velders L, et al. Association of cyclophosphamide drug-metabolizing enzyme polymorphisms and chemotherapy-related ovarian failure in breast cancer survivors. Fertil Steril. 2010; 94 ( 2 ): 645 - 654.
dc.identifier.citedreferencevan der Perk MEM, Broer L, Yasui Y, et al. Effect of genetic variation in CYP450 on gonadal impairment in a European cohort of female childhood cancer survivors, based on a candidate gene approach: results from the PanCareLIFE study. Cancer. 2021; 13 ( 18 ). doi: 10.3390/cancers13184598
dc.identifier.citedreferenceGreither T, Schumacher J, Dejung M, et al. Fertility relevance probability analysis shortlists genetic markers for male fertility impairment. Cytogenet Genome Res. 2020; 160 ( 9 ): 506 - 522.
dc.identifier.citedreferenceD’Angio GJ. Pediatric cancer in perspective: cure is not enough. Cancer. 1975; 35 ( 3 Suppl ): 866 - 870.
dc.identifier.citedreferenceThompson KA. Pregnancy and cardiomyopathy after anthracyclines in childhood. Front Cardiovasc Med. 2018; 5: 14.
dc.identifier.citedreferencede Kraker J, Graf N, van Tinteren H, et al. Reduction of postoperative chemotherapy in children with stage I intermediate-risk and anaplastic Wilms’ tumour (SIOP 93-01 trial): a randomised controlled trial. Lancet. 2004; 364 ( 9441 ): 1229 - 1235.
dc.identifier.citedreferenceGraf N, van Tinteren H, Bergeron C, et al. Characteristics and outcome of stage II and III non-anaplastic Wilms’ tumour treated according to the SIOP trial and study 93-01. Eur J Cancer. 2012; 48 ( 17 ): 3240 - 3248.
dc.identifier.citedreferenceGreen DM, Breslow NE, D’Angio GJ, et al. Outcome of patients with stage II/favorable histology Wilms tumor with and without local tumor spill: a report from the National Wilms Tumor Study Group. Pediatr Blood Cancer. 2014; 61 ( 1 ): 134 - 139.
dc.identifier.citedreferencePritchard-Jones K, Moroz V, Vujanic G, et al. Treatment and outcome of Wilms’ tumour patients: an analysis of all cases registered in the UKW3 trial. Ann Oncol. 2012; 23 ( 9 ): 2457 - 2463.
dc.identifier.citedreferenceWeirich A, Ludwig R, Graf N, et al. Survival in nephroblastoma treated according to the trial and study SIOP-9/GPOH with respect to relapse and morbidity. Ann Oncol. 2004; 15 ( 5 ): 808 - 820.
dc.identifier.citedreferenceArmstrong GT, Sklar CA, Hudson MM, Robison LL. Long-term health status among survivors of childhood cancer: does sex matter? J Clin Oncol. 2007; 25 ( 28 ): 4477 - 4489.
dc.identifier.citedreferencevan den Berg MH, Overbeek A, Lambalk CB, et al. Long-term effects of childhood cancer treatment on hormonal and ultrasound markers of ovarian reserve. Hum Reprod. 2018; 33 ( 8 ): 1474 - 1488.
dc.identifier.citedreferenceBrok J, Treger TD, Gooskens SL, van den Heuvel-Eibrink MM, Pritchard-Jones K. Biology and treatment of renal tumours in childhood. Eur J Cancer. 2016; 68: 179 - 195.
dc.identifier.citedreferenceDome JS, Graf N, Geller JI, et al. Advances in Wilms tumor treatment and biology: progress through international collaboration. J Clin Oncol. 2015; 33 ( 27 ): 2999 - 3007.
dc.identifier.citedreferenceMulder RL, Font-Gonzalez A, Green DM, et al. Fertility preservation for male patients with childhood, adolescent, and young adult cancer: recommendations from the PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group. Lancet Oncol. 2021; 22 ( 2 ): e57 - e67.
dc.identifier.citedreferenceMulder RL, Font-Gonzalez A, Hudson MM, et al. Fertility preservation for female patients with childhood, adolescent, and young adult cancer: recommendations from the PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group. Lancet Oncol. 2021; 22 ( 2 ): e45 - e56.
dc.identifier.citedreferenceVujanic GM, Gessler M, Ooms A, et al. The UMBRELLA SIOP-RTSG 2016 Wilms tumour pathology and molecular biology protocol. Nat Rev Urol. 2018; 15 ( 11 ): 693 - 701.
dc.identifier.citedreferenceJanssens GO, Melchior P, Mul J, et al. The SIOP-Renal Tumour Study Group consensus statement on flank target volume delineation for highly conformal radiotherapy. Lancet Child Adolesc Health. 2020; 4 ( 11 ): 846 - 852.
dc.identifier.citedreferencePortela JMD, de Winter-Korver CM, van Daalen SKM, et al. Assessment of fresh and cryopreserved testicular tissues from (pre)pubertal boys during organ culture as a strategy for in vitro spermatogenesis. Hum Reprod. 2019; 34 ( 12 ): 2443 - 2455.
dc.identifier.citedreferencePractice Committee of the American Society for Reproductive Medicine. Electronic address aao. Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion. Fertil Steril. 2019; 112 ( 6 ): 1022 - 1033.
dc.identifier.citedreferenceUijldert M, Meissner A, de Melker AA, et al. Development of the testis in pre-pubertal boys with cancer after biopsy for fertility preservation. Hum Reprod. 2017; 32 ( 12 ): 2366 - 2372.
dc.identifier.citedreferencevan der Perk MEM, van der Kooi ALF, van de Wetering MDIMIJ, van Dulmen-den Broeder E, Broer SL, et al. Oncofertility care for newly diagnosed girls with cancer in a national pediatric oncology setting, the first full year experience from the Princess Maxima Center, the PEARL study. PLoS One. 2021; 16 ( 3 ): e0246344.
dc.identifier.citedreferencevan der Kooi ALF, Mulder RL, Hudson MM, et al. Counseling and surveillance of obstetrical risks for female childhood, adolescent, and young adult cancer survivors: recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Am J Obstet Gynecol. 2021; 224 ( 1 ): 3 - 15.
dc.identifier.citedreferencevan Dorp W, Mulder RL, Kremer LC, et al. Recommendations for premature ovarian insufficiency surveillance for female survivors of childhood, adolescent, and young adult cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in Collaboration with the PanCareSurFup Consortium. J Clin Oncol. 2016; 34 ( 28 ): 3440 - 3450.
dc.identifier.citedreferenceJayasuriya S, Peate M, Allingham C, et al. Satisfaction, disappointment and regret surrounding fertility preservation decisions in the paediatric and adolescent cancer population. J Assist Reprod Genet. 2019; 36 ( 9 ): 1805 - 1822.
dc.identifier.citedreferencePanagiotopoulou N, van Delft FW, Stewart JA. Fertility preservation knowledge, attitudes and intentions among children by proxy and adolescents with cancer. Reprod Biomed Online. 2019; 39 ( 5 ): 802 - 808.
dc.identifier.citedreferenceShnorhavorian M, Harlan LC, Smith AW, et al. Fertility preservation knowledge, counseling, and actions among adolescent and young adult patients with cancer: a population-based study. Cancer. 2015; 121 ( 19 ): 3499 - 3506.
dc.identifier.citedreferenceArmuand GM, Wettergren L, Rodriguez-Wallberg KA, Lampic C. Desire for children, difficulties achieving a pregnancy, and infertility distress 3 to 7 years after cancer diagnosis. Support Care Cancer. 2014; 22 ( 10 ): 2805 - 2812.
dc.identifier.citedreferenceBenedict C, Thom B, Kelvin JF. Young adult female cancer survivors’ decision regret about fertility preservation. J Adolesc Young Adult Oncol. 2015; 4 ( 4 ): 213 - 218.
dc.identifier.citedreferenceSu HI, Lee YT, Barr R. Oncofertility: meeting the fertility goals of adolescents and young adults with cancer. Cancer J. 2018; 24 ( 6 ): 328 - 335.
dc.identifier.citedreferenceWyns C, Collienne C, Shenfield F, et al. Fertility preservation in the male pediatric population: factors influencing the decision of parents and children. Hum Reprod. 2015; 30 ( 9 ): 2022 - 2030.
dc.identifier.citedreferenceGupta AA, Edelstein K, Albert-Green A, D’Agostino N. Assessing information and service needs of young adults with cancer at a single institution: the importance of information on cancer diagnosis, fertility preservation, diet, and exercise. Support Care Cancer. 2013; 21 ( 9 ): 2477 - 2484.
dc.identifier.citedreferenceDeshpande NA, Braun IM, Meyer FL. Impact of fertility preservation counseling and treatment on psychological outcomes among women with cancer: a systematic review. Cancer. 2015; 121 ( 22 ): 3938 - 3947.
dc.identifier.citedreferenceJardim FA, Lopes-Junior LC, Nascimento LC, Neves ET, Lima RAG. Fertility-related concerns and uncertainties in adolescent and young adult childhood cancer survivors. J Adolesc Young Adult Oncol. 2021; 10 (1):85-91. doi: 10.1089/jayao.2020.0058
dc.identifier.citedreferenceLetourneau JM, Ebbel EE, Katz PP, et al. Pretreatment fertility counseling and fertility preservation improve quality of life in reproductive age women with cancer. Cancer. 2012; 118 ( 6 ): 1710 - 1717.
dc.identifier.citedreferenceNewton K, Howard AF, Thorne S, Kelly MT, Goddard K. Facing the unknown: uncertain fertility in young adult survivors of childhood cancer. J Cancer Surv. 2020; 15: 54 - 65. doi: 10.1007/s11764-020-00910-x
dc.identifier.citedreferenceSkaczkowski G, White V, Thompson K, et al. Factors influencing the provision of fertility counseling and impact on quality of life in adolescents and young adults with cancer. J Psychosoc Oncol. 2018; 36 ( 4 ): 484 - 502.
dc.identifier.citedreferenceFont-Gonzalez A, Mulder RL, van Dulmen-den Broeder E, et al. Recommendations for communication and ethical considerations related to fertility preservation in children, adolescents and young adult cancer patients: a report from the PanCareLIFE consortium in collaboration with the International Late Effects of Childhood Cancer Guideline Harmonization Group. Lancet Oncol. 2021; 22 (2):e68-e80.
dc.identifier.citedreferenceFlink DM, Sheeder J, Kondapalli LA. A review of the oncology patient’s challenges for utilizing fertility preservation services. J Adolesc Young Adult Oncol. 2017; 6 ( 1 ): 31 - 44.
dc.identifier.citedreferenceDaw NC, Anderson J, Kalapurakal JA, Hoffer FA. Treatment of stage II–IV diffuse anaplastic wilms tumor: results from the children’s oncology group AREN0321 study. Pediatr Blood Cancer. 2014; 61: S113.
dc.identifier.citedreferenceMalogolowkin M, Cotton CA, Green DM, et al. Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the National Wilms Tumor Study Group. Pediatr Blood Cancer. 2008; 50 ( 2 ): 236 - 241.
dc.identifier.citedreferenceFernandez CV, Perlman EJ, Mullen EA, et al. Clinical outcome and biological predictors of relapse after nephrectomy only for very low-risk Wilms tumor: a report from Children’s Oncology Group AREN0532. Ann Surg. 2017; 265 ( 4 ): 835 - 840.
dc.identifier.citedreferenceDix DB, Fernandez CV, Chi YY, et al. Augmentation of therapy for combined loss of heterozygosity 1p and 16q in favorable histology Wilms tumor: a Children’s Oncology Group AREN0532 and AREN0533 study report. J Clin Oncol. 2019; 37 ( 30 ): 2769 - 2777.
dc.identifier.citedreferenceDix DB, Seibel NL, Chi YY, et al. Treatment of stage IV favorable histology Wilms tumor with lung metastases: a report from the Children’s Oncology Group AREN0533 study. J Clin Oncol. 2018; 36 ( 16 ): 1564 - 1570.
dc.identifier.citedreferenceGrundy PE, Breslow NE, Li S, et al. Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group. J Clin Oncol. 2005; 23 ( 29 ): 7312 - 7321.
dc.identifier.citedreferenceDaw NC, Chi YY, Kim Y, et al. Treatment of stage I anaplastic Wilms’ tumour: a report from the Children’s Oncology Group AREN0321 study. Eur J Cancer. 2019; 118: 58 - 66.
dc.identifier.citedreferenceDaw NC, Chi YY, Kalapurakal JA, et al. Activity of vincristine and irinotecan in diffuse anaplastic Wilms tumor and therapy outcomes of stage II to IV disease: results of the Children’s Oncology Group AREN0321 study. J Clin Oncol. 2020; 38 ( 14 ): 1558 - 1568.
dc.identifier.citedreferenceFernandez CV, Mullen EA, Chi YY, et al. Outcome and prognostic factors in stage III favorable-histology Wilms tumor: a report from the Children’s Oncology Group Study AREN0532. J Clin Oncol. 2018; 36 ( 3 ): 254 - 261.
dc.identifier.citedreferencevan den Heuvel-Eibrink MM, van Tinteren H, Bergeron C, et al. Outcome of localised blastemal-type Wilms tumour patients treated according to intensified treatment in the SIOP WT 2001 protocol, a report of the SIOP Renal Tumour Study Group (SIOP-RTSG). Eur J Cancer. 2015; 51 ( 4 ): 498 - 506.
dc.identifier.citedreferencePritchard-Jones K, Bergeron C, de Camargo B, et al. Omission of doxorubicin from the treatment of stage II-III, intermediate-risk Wilms’ tumour (SIOP WT 2001): an open-label, non-inferiority, randomised controlled trial. Lancet. 2015; 386 ( 9999 ): 1156 - 1164.
dc.identifier.citedreferenceHa TC, Spreafico F, Graf N, et al. An international strategy to determine the role of high dose therapy in recurrent Wilms’ tumour. Eur J Cancer. 2013; 49 ( 1 ): 194 - 210.
dc.identifier.citedreferenceAnderson RA, Mitchell RT, Kelsey TW, Spears N, Telfer EE, Wallace WH. Cancer treatment and gonadal function: experimental and established strategies for fertility preservation in children and young adults. Lancet Diabetes Endocrinol. 2015; 3 ( 7 ): 556 - 567.
dc.identifier.citedreferencevan Dorp W, Haupt R, Anderson RA, et al. Reproductive function and outcomes in female survivors of childhood, adolescent, and young adult cancer: a review. J Clin Oncol. 2018; 36 ( 21 ): 2169 - 2180.
dc.identifier.citedreferenceOverbeek A, van den Berg MH, van Leeuwen FE, Kaspers GJ, Lambalk CB, van Dulmen-den BE. Chemotherapy-related late adverse effects on ovarian function in female survivors of childhood and young adult cancer: a systematic review. Cancer Treat Rev. 2017; 53: 10 - 24.
dc.identifier.citedreferenceSudour H, Chastagner P, Claude L, et al. Fertility and pregnancy outcome after abdominal irradiation that included or excluded the pelvis in childhood tumor survivors. Int J Radiat Oncol Biol Phys. 2010; 76 ( 3 ): 867 - 873.
dc.identifier.citedreferencePractice Committee of the American Society for Reproductive M. Testing and interpreting measures of ovarian reserve: a committee opinion. Fertil Steril. 2012; 98 ( 6 ): 1407 - 1415.
dc.identifier.citedreferenceChemaitilly W, Li Z, Krasin MJ, et al. Premature ovarian insufficiency in childhood cancer survivors: a report from the St. Jude lifetime cohort. J Clin Endocrinol Metabol. 2017; 102 ( 7 ): 2242 - 2250.
dc.identifier.citedreferenceGreen DM, Nolan VG, Goodman PJ, et al. The cyclophosphamide equivalent dose as an approach for quantifying alkylating agent exposure: a report from the Childhood Cancer Survivor Study. Pediatr Blood Cancer. 2014; 61 ( 1 ): 53 - 67.
dc.identifier.citedreferenceGreen DM, Kawashima T, Stovall M, et al. Fertility of female survivors of childhood cancer: a report from the childhood cancer survivor study. J Clin Oncol. 2009; 27 ( 16 ): 2677 - 2685.
dc.identifier.citedreferenceChow EJ, Stratton KL, Leisenring WM, et al. Pregnancy after chemotherapy in male and female survivors of childhood cancer treated between 1970 and 1999: a report from the Childhood Cancer Survivor Study cohort. Lancet Oncol. 2016; 17 ( 5 ): 567 - 576.
dc.identifier.citedreferenceKenney LB, Laufer MR, Grant FD, Grier H, Diller L. High risk of infertility and long term gonadal damage in males treated with high dose cyclophosphamide for sarcoma during childhood. Cancer. 2001; 91 ( 3 ): 613 - 621.
dc.identifier.citedreferenceWasilewski-Masker K, Seidel KD, Leisenring W, et al. Male infertility in long-term survivors of pediatric cancer: a report from the childhood cancer survivor study. J Cancer Surviv Res Pract. 2014; 8 ( 3 ): 437 - 447.
dc.identifier.citedreferenceLehmann V, Chemaitilly W, Lu L, et al. Gonadal functioning and perceptions of infertility risk among adult survivors of childhood cancer: a report from the St Jude Lifetime Cohort Study. J Clin Oncol. 2019; 37 ( 11 ): 893 - 902.
dc.identifier.citedreferenceMeistrich ML. Effects of chemotherapy and radiotherapy on spermatogenesis in humans. Fertil Steril. 2013; 100 ( 5 ): 1180 - 1186.
dc.identifier.citedreferenceGreen DM, Kawashima T, Stovall M, et al. Fertility of male survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Clin Oncol. 2010; 28 ( 2 ): 332 - 339.
dc.identifier.citedreferenceThomas PR, Tefft M, Compaan PJ, Norkool P, Breslow NE, D’Angio GJ. Results of two radiation therapy randomizations in the third National Wilms’ Tumor Study. Cancer. 1991; 68 ( 8 ): 1703 - 1707.
dc.identifier.citedreferenceDome JS, Cotton CA, Perlman EJ, et al. Treatment of anaplastic histology Wilms’ tumor: results from the fifth National Wilms’ Tumor Study. J Clin Oncol. 2006; 24 ( 15 ): 2352 - 2358.
dc.identifier.citedreferencevan den Heuvel-Eibrink MM, Hol JA, Pritchard-Jones K, et al. Position paper: rationale for the treatment of Wilms tumour in the UMBRELLA SIOP-RTSG 2016 protocol. Nat Rev Urol. 2017; 14 ( 12 ): 743 - 752.
dc.identifier.citedreferenceDavila Fajardo R, Oldenburger E, Rube C, et al. Evaluation of boost irradiation in patients with intermediate-risk stage III Wilms tumour with positive lymph nodes only: results from the SIOP-WT-2001 Registry. Pediatr Blood Cancer. 2018; 65 ( 8 ): e27085.
dc.identifier.citedreferenceFajardo RD, van den Heuvel-Eibrink MM, van Tinteren H, et al. Is radiotherapy required in first-line treatment of stage I diffuse anaplastic Wilms tumor? A report of SIOP-RTSG, AIEOP, JWiTS, and UKCCSG. Pediatr Blood Cancer. 2020; 67 ( 2 ): e28039.
dc.identifier.citedreferenceBardo DM, Black M, Schenk K, Zaritzky MF. Location of the ovaries in girls from newborn to 18 years of age: reconsidering ovarian shielding. Pediatr Radiol. 2009; 39 ( 3 ): 253 - 259.
dc.identifier.citedreferenceMul J, Seravalli E, Bosman ME, et al. Estimated clinical benefit of combining highly conformal target volumes with Volumetric-Modulated Arc Therapy (VMAT) versus conventional flank irradiation in pediatric renal tumors. Clin Transl Radiat Oncol. 2021; 29: 20 - 26.
dc.identifier.citedreferenceMul J, van Grotel M, Seravalli E, et al. Locoregional control using highly conformal flank target volumes and volumetric-modulated arc therapy in pediatric renal tumors: results from the Dutch national cohort. Radiother Oncol. 2021; 159: 249 - 254.
dc.identifier.citedreferencePerrone L, Sinisi AA, Sicuranza R, et al. Prepubertal endocrine follow-up in subjects with Wilms’ tumor. Med Pediatr Oncol. 1988; 16 ( 4 ): 255 - 258.
dc.identifier.citedreferenceShalet SM, Beardwell CG, Jacobs HS, Pearson D. Testicular function following irradiation of the human prepubertal testis. Clin Endocrinol (Oxf). 1978; 9 ( 6 ): 483 - 490.
dc.identifier.citedreferenceNussbaum Blask AR, Nicholson HS, Markle BM, Wechsler-Jentzch K, O’Donnell R, Byrne J. Sonographic detection of uterine and ovarian abnormalities in female survivors of Wilms’ tumor treated with radiotherapy. AJR Am J Roentgenol. 1999; 172 ( 3 ): 759 - 763.
dc.identifier.citedreferenceGreen DM, Peabody EM, Nan B, Peterson S, Kalapurakal JA, Breslow NE. Pregnancy outcome after treatment for Wilms tumor: a report from the National Wilms Tumor Study Group. J Clin Oncol. 2002; 20 ( 10 ): 2506 - 2513.
dc.identifier.citedreferenceDenzer C. Disorders of gonadal and reproductive function in survivors of childhood and adolescent cancer. In: Beck JD, Bokemeyer C, Langer T, eds. Late Treatment Effects and Cancer Survivor Care in the Young. Cham: Springer; 2021: 87 - 95.
dc.identifier.citedreferenceGreen DM, Lange JM, Peabody EM, et al. Pregnancy outcome after treatment for Wilms tumor: a report from the national Wilms tumor long-term follow-up study. J Clin Oncol. 2010; 28 ( 17 ): 2824 - 2830.
dc.identifier.citedreferenceKalapurakal JA, Peterson S, Peabody EM, et al. Pregnancy outcomes after abdominal irradiation that included or excluded the pelvis in childhood Wilms tumor survivors: a report from the National Wilms Tumor Study. Int J Radiat Oncol Biol Phys. 2004; 58 ( 5 ): 1364 - 1368.
dc.identifier.citedreferenceLi FP, Gimbrere K, Gelber RD, et al. Outcome of pregnancy in survivors of Wilms’ tumor. JAMA. 1987; 257 ( 2 ): 216 - 219.
dc.identifier.citedreferenceByrne J, Mulvihill JJ, Connelly RR, et al. Reproductive problems and birth defects in survivors of Wilms’ tumor and their relatives. Med Pediatr Oncol. 1988; 16 ( 4 ): 233 - 240.
dc.identifier.citedreferenceWallace WH, Thomson AB, Saran F, Kelsey TW. Predicting age of ovarian failure after radiation to a field that includes the ovaries. Int J Radiat Oncol Biol Phys. 2005; 62 ( 3 ): 738 - 744.
dc.identifier.citedreferencePater L, Melchior P, Rube C, et al. Wilms tumor. Pediatr Blood Cancer. 2021; 68 ( Suppl 2 ): e28257.
dc.identifier.citedreferencevan Santen HM, van de Wetering MD, Bos AME, Vd Heuvel-Eibrink MM, van der Pal HJ, Wallace WH. Reproductive complications in childhood cancer survivors. Pediatr Clin North Am. 2020; 67 ( 6 ): 1187 - 1202.
dc.identifier.citedreferenceESHRE Guideline Group on Female Fertility Preservation, Anderson RA, Amant F, et al. ESHRE guideline: female fertility preservation. Hum Reprod Open. 2020; 2020 ( 4 ): hoaa052.
dc.identifier.citedreferenceKlipstein S, Fallat ME, Savelli S, Committee On Bioethics; Section on Hematology/Oncology; Section on Surgery. Fertility preservation for pediatric and adolescent patients with cancer: medical and ethical considerations. Pediatrics. 2020; 145 ( 3 ):e20193994. doi: 10.1542/peds.2019-3994
dc.identifier.citedreferenceFuchs A, Kashanian JA, Clayman ML, et al. Pediatric oncology providers’ attitudes and practice patterns regarding fertility preservation in adolescent male cancer patients. J Pediatr Hematol Oncol. 2016; 38 ( 2 ): 118 - 122.
dc.identifier.citedreferenceGoodwin T, Elizabeth Oosterhuis B, Kiernan M, Hudson MM, Dahl GV. Attitudes and practices of pediatric oncology providers regarding fertility issues. Pediatr Blood Cancer. 2007; 48 ( 1 ): 80 - 85.
dc.identifier.citedreferenceAdams E, Hill E, Watson E. Fertility preservation in cancer survivors: a national survey of oncologists’ current knowledge, practice and attitudes. Br J Cancer. 2013; 108 ( 8 ): 1602 - 1615.
dc.identifier.citedreferenceLouwe LA, ter Kuile MM, Hilders CG, et al. Oncologists’ practice and attitudes regarding fertility preservation in female cancer patients: a pilot study in the Netherlands. J Psychosom Obstet Gynaecol. 2013; 34 ( 3 ): 129 - 132.
dc.identifier.citedreferenceDolmans MM, Taylor HS, Rodriguez-Wallberg KA, et al. Utility of gonadotropin-releasing hormone agonists for fertility preservation in women receiving chemotherapy: pros and cons. Fertil Steril. 2020; 114 ( 4 ): 725 - 738.
dc.identifier.citedreferenceHalpern JA, Das A, Faw CA, Brannigan RE. Oncofertility in adult and pediatric populations: options and barriers. Transl Androl Urol. 2020; 9 ( Suppl 2 ): S227 - S238.
dc.identifier.citedreferenceLambertini M, Peccatori FA, Demeestere I, et al. Fertility preservation and post-treatment pregnancies in post-pubertal cancer patients: ESMO Clinical Practice Guidelines. Ann Oncol. 2020; 31 ( 12 ): 1664 - 1678.
dc.identifier.citedreferenceMoravek MB, Appiah LC, Anazodo A, et al. Development of a pediatric fertility preservation program: a report from the Pediatric Initiative Network of the Oncofertility Consortium. J Adolesc Health. 2019; 64 ( 5 ): 563 - 573.
dc.identifier.citedreferenceTanner JM. Growth at Adolescence. 2nd ed. Oxford, England: Blackwell Scientific Publications; 1962.
dc.working.doiNOen
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
ijc34006_am.pdf
Size:
550.4KB
Format:
PDF
View/Open
Name:
ijc34006.pdf
Size:
1.077MB
Format:
PDF
View/Open
Name:
ijc34006-sup-0001-Supinfo.pdf
Size:
862.5KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.